Metformin attenuates gefitinib-induced exacerbation of pulmonary fibrosis by inhibition of TGF-β signaling pathway
Cited by 93
Related Papers
Osimertinib or Platinum–Pemetrexed in <i>EGFR</i> T790M–Positive Lung Cancer
|New England Journal of Medicine|2016|3.3k
Metformin Inhibits the IL-6-Induced Epithelial-Mesenchymal Transition and Lung Adenocarcinoma Growth and Metastasis
|PLoS ONE|2014|107
Metformin restores crizotinib sensitivity in crizotinib-resistant human lung cancer cells through inhibition of IGF1-R signaling pathway
|Oncotarget|2016|46
Combined treatment with metformin and gefitinib overcomes primary resistance to EGFR-TKIs with EGFR mutation via targeting IGF-1R signaling pathway
|Biologics|2018|34
A novel P53/<scp>POMC</scp>/Gαs/<scp>SASH</scp>1 autoregulatory feedback loop activates mutated <scp>SASH</scp>1 to cause pathologic hyperpigmentation
|Journal of Cellular and Molecular Medicine|2016|26